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Abstract
Gastroesophageal disease (GERD) is the one of most spread diseases that injures an esophagus. Taking into account the large 
number of factors that can cause GERD development already in child age, including genetic predisposition, it is necessary to analyze 
each of them in detail. 
Aim of this work was to analyze a frequency and possible association type of р. Leu72Met mutation of GHRL gene in chil-
dren with gastroesophageal reflux disease. 
The analysis of clinical parameters and course of disease in the group of 100 schoolchildren with GERD was carried out. The 
molecular-genetic study of c.214C>A locus of GHRL gene by CPR method (rs696217) was carried out in patients with GERD and 
40 healthy children from the control group. 
In 82 % of children with GERD was revealed a GHRL 214СС (Leu/Leu) homozygous genotype, at 58 % among children 
from the control group. GHRL 214СА (Leu/ Met) genotype was registered three times more seldom in children of the studied group 
comparing with ones from the control group: 15,0 % and 42,5 %, respectively. It was established, that GHRL 214CС genotype pres-
ence conditions the increase of GERD development risk in 3,4 times. On the contrary, GHRL 214CА genotype manifests a reliable 
protective effect that is essentially decreased GERD development risk in a child at such genotype – 0,24 comparing with a conven-
tional unit. 
There was established alleles and genotypes distribution of c.214C>A (р.Leu72Met) locus of GHRL gene in children with 
GERD. GHRL 214CС genotype is associated with threefold increase of GERD risk development. Gender differences as to GERD de-
velopment risk at different genotypes of ghrelin gene were established. At GHRL 214СС (Leu/Leu) genotype the relative GERD risk 
for boys increased in more than 6 times. There were not established any differences in alleles and genotypes distribution depending 
on erosive or surface inflammatory changes of a gastrointestinal tract mucosa. 
Keywords: gastroesophageal reflux disease, children, ghrelin, Leu72Met mutation. 
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1. Introduction
For today the one of cases of gastroesophageal reflux disease (GERD) is considered as a 
disorder of gastrointestinal tract upper parts motility with further emission of gastric acid in an 
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esophagus. The inhibition of stomach emptying is a risk factor of GERD development and is ob-
served nearly in 10−40 % of patients (Festi and others, 2009) [1, 2]. The regular irritation of an 
esophagus mucosa by gastric acid causes inflammatory changes and in some cases erosions or 
ulcers. The distinct correlation was established between the duration of stomach content effect 
on an esophagus and severity degree of its mucosa injury [3]. It is well-known, that stimulation of 
gastrointestinal tract motility and appetite are greatly influenced by ghrelin (GHRL) [4, 5]. Ghrelin, 
orexigenic motilin-like hormone, discovered in 1996 by M. Kojima and his colleges, who reported 
about it in 1999 [6]. The most amount of ghrelin (over 90 %) is in a stomach and duodenum. Lower 
amounts were reveled in a placenta [7], hypophysis, arched kernel of hypothalamus [8]. Ghrelin can 
increase a speed of stomach emptying and so, decrease an amount of gastric acid that reaches an 
esophagus. Ghrelin anti-inflammatory effects were also presented in the studies by Golestan and 
others, 2010; Nikoukar and others, 2014. Thus, ghrelin has a positive influence on an esophagus 
mucosa through anti-inflammatory mechanisms [2]. Ghrelin secretion increases under conditions 
of the negative energetic balance such as hunger, cachexy and anorexia, whereas its expression 
decreases under conditions of the positive energetic balance such as feeding, hyperglycemia and 
obesity [9]. Ghrelin is expressed by GHRL gene, several SNP are informed for it. In literature is 
actively studied the SNP allele polymorphism with obesity [10, 11], food behavior disorders [12] 
and metabolism disturbances [13], and also with gastric acid secretion [14] and fast stomach emp-
tying [15, 16]. Mutations in this gene can cause low levels of ghrelin, registered at obesity [17].
2. Aim of research
To analyze the frequency and possible association type of р. Leu72Met mutation of GHRL 
in children with gastroesophageal disease. 
3. Materials and methods
The studied group consisted of 100 children 6−14 years old (in average 10,8 years), who 
underwent the stationary treatment at I-st pediatric department of the Municipal institution of Lviv 
regional council Lviv regional child clinical hospital (MI LRC LRCH “OHMADIT”) with a diag-
nosed pathology of gastrointestinal tract. The control group included 40 of the same age without 
any gastrointestinal tract pathology. Among the children of studied group were 44 boys (44±9,6 %) 
and 56 girls (56±9,6 %). All children underwent esophagogastroduodenoscopy using the videogas-
troscop “Fujinon” WG 88 FP, sonographic study of abdominal cavity organs, general clinical and 
laboratory studies, anamnestic data were analyzed. The group of 40 children without any manifes-
tations of gastroesophageal reflux disease was formed as a control. The material of the study was 
40 samples of DNA, separated from cells of bucal epithelium. 
DNA of peripheral blood leucocytes was separated and purified by salting out method. 
PCR was carried out in automatic regime on the thermocycler “Tertsik” („DNA-technology, Rus-
sia), oligonucleotide primers, mixture of dDNTP and thermostable DNA-polymerase Thermo 
Scientific™ were used. The fragment of gene with the size 373 b. p. was amplified using primers 
(GREL2F 5’- TGA CCT CAC TGT TTC TGG AAG-’, GREL2R 5’-GGA CCC TGT TCA CTG 
CCA C-3’). The analysis of PCR products was carried out by PRFL (polymorphism of restrictive 
fragments lengths) method. Amplification products were visualized by electrophoresis in 2 % 
agarose gel with ethidium bromide and scanned on the ultraviolet transiluminator “ECX-15. M 
(VILBER LOURMAT, France). The received signals were compared with lengths markers and 
sizes of received fragments were detected on this base. The results of agarose gel scanning were 
photographed by the digital camera “Gel Imager” (HELICON, Russia). The received data process-
ing was carried out by conventional method of variational statistics with the calculation of odds 
ratio coefficient at 95 % credible interval. 
4. Results
The anamnesis and course of gastrointestinal tract diseases were analyzed in 300 school-
children. The criteria of inclusion in the studied group: complaints about gastrointestinal tract (pain 
in epigastral zone, nausea, heartburn, eructation, vomiting), apparent changes at the examination of 
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gastrointestinal tract organs using additional methods, voluntary consent of parents for genetic ex-
amination. The criteria of exclusion: refusal of the examination at any stage. The results, received 
at the endoscopic examination were interpreted using Savari-Miller classification in G. N. J. Tytgat 
et. al. modification, 1990. For setting the diagnosis “functional dyspepsia”, the Roman criteria IV 
were used. Among diseases of gastrointestinal tract in the studied group were revealed: erosive 
changes (erosive esophagitis, erosive gastritis, erosive duodenitis) – 16 children that is 16±7 % 
(4 girls and 11 boys); surface inflammatory changes (distal esophagitis, surface gastritis, surface 
duodenitis) – 84 children that is 84±7 % (48 girls and 32 boys). Gastroesophageal reflux disease 
with esophagitis was diagnosed most often among children of the studied group (59±9 %). On the 
second place by revelation frequency was a gastroesophageal reflux disease without esophagitis 
(26±8 %). Functional dyspepsia and a combination of duodenogastral and gastroesophagal reflux 
occurred in 10±6 % and in 15±7 %, respectively. There was not revealed any reliable difference in 
the frequency of gastrointestinal tract diseases depending on sex. 
All children of the studied group underwent the molecular-genetic examination of alleles of Leu-
72Met locus of GHRL gene. As a result of PCR product processing by endonuclease of BsrI restriction, 
fragments with the following sizes were visualized on electrophoreogram: 373 b. p. − 214АА (Met/Met) 
genotype, 373 b. p. 272 b.p. and 101 b. p. – 214CА (Leu/Met) genotype, 272 b. p. and 101 b. p – 214СС 
(Leu/Leu) genotype, respectively. The electrophoreogram of molecular-genetic study of Leu72Met 
polymorphism of GHRL gene is presented on the Fig. 1. 
Fig. 1. Electrophoreogram of restrictive analysis of PCR products of SNP c.214C>A, р. Leu72Met 
polymorphism of GHRL gene 1 (2 % agarose gel): 1-Met/Met genotype (373 b. p.); 2,4,5-Leu/Met 
genotype (373 b. p., 272 b. p., 101 b. p.); 3-Leu/Leu genotype (272 b. p., 101 b. p.)
As a result of DNA molecular-genetic analysis in 100 persons of the studied group with GERD 
and 40 persons from the control group there was established a genotype as to р.Leu72Met polymor-
phic locus of GHRL gene. One-nucleotide polymorphism is conditioned by cytosine (214C allele) 
replacement by adenine (214А allele) and, correspondingly, amino acid replacement of leucine by 
methionine − Leu72Met. In 82 % of children with GERD was revealed GHRL 214СС (Leu/Leu) ho-
mozygous genotype, at 58 % among children of the control group. GHRL 214СА (Leu/Met) genotype 
was registered three times more seldom in children of the studied group comparing with ones from 
the control group: 15,0 % and 42,5 %, respectively. The results of genotypes distribution in children 
with GERD comparing with the control are presented on the Fig. 2.
As a result of the molecular-genetic analysis there were established statistically reliable 
differences in the ratio of GHRL gene genotypes between the group of children with GERD com-
paring with the control sample (χ2=12,94, р=0,002). The calculated coefficients of GERD odds ratio 
dependence on c.214C>A locus alleles of ghrelin gene are presented in the Table 1.
Taking into account the revealed differences as to р.Leu72Met polymorphic locus geno-
types distribution of GHRL gene in children with GERD comparing with the control group, it 
was considered expedient to study allele frequency in the analyzed samples. Allele frequency 
indices of р. Leu72Met locus of GHRL gene in the studied groups of child patients are presented 
in the Table 2.
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Fig. 2. Distribution of р.Leu72Met polymorphous locus genotypes of GHRL gene in children with 
GERD comparing with the control (χ2=12,94, р=0,002)
Table 1
Distribution of p. Leu72Met polymorphous locus genotypes of GHRL gene in studied groups 
GHRL genotype
Studied group, % Control group, %
χ2 p
OR
n=100 n = 40 value 95 % CI
GHRL 214СС 82,0 57,5
12,94 0,002*
3,37 1,50–7,56
GHRL 214CА 15,0 42,5 0,24 0,10–0,55
GHRL 214АА 3,0 0,0 2,91 0,15–57,58
Note: n – number of persons, р – significance of differences in genotypes distribution between control and studied groups, * – sta-
tistically reliable value, OR – odds ratio coefficient 
Table 2
Allele frequency of р. Leu72Met polymorphous locus of GHRL gene in the studied groups 
Alleles of  
GHRL gene
Frequency, %
χ2 p
OR
Studied group, %
n = 100
Control group, %
n = 40 value 95 % CI
GHRL 214С 89,5 78,8
5,63 0,02*
2,30 1,14–4,64
GHRL 214А 10,5 21,3 0,43 0,22–0,88
Note: n – number of persons, р – significance of differences between control and studied groups, * – statistically reliable value, 
OR – odds ratio coefficient 
As it is testified by the results, presented in the table 2, statistically reliable differences were 
established in the frequencies of normal C and low-functional A alleles of c.214C>A (р. Leu72Met) 
locus of GHRL gene in the studied groups of patients (χ2=5,63, р<0,05). The calculation of the odds 
ratio coefficient revealed a reliable effect as to А allele: OR=0,43, СІ: 0,22–0,88 and association 
of C allele with the reliable increase of GERD risk in 2,3 times at the credible interval 1,14–4,64. 
Gender differences as to alleles and genotypes distribution of c.Leu72Met locus of GHRL 
gene were analyzed (Table 3). 
Thus, in 83,9 % of girls and 79,5 % of boys with GERD was revealed GHRL 214CC – Leu/Leu 
homozygous genotype that was similar to girls of the control group. The essential difference at gender 
analysis was observed among boys: the frequency of GHRL Leu/Met heterozygous genotype among 
boys of the studied group was 16 % and 60 % in the control (р= 0,01). 
On the Fig. 3 is presented the distribution in established genotype groups depending on 
injures severity (erosive changes and surface inflammatory changes) of a gastrointestinal tract. 
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Table 3
Genotypes distribution of c. Leu72Met polymorphous locus of GHRL gene depending on sex of patients of 
the studied groups 
Genotype
GHRL 
Girls Boys 
Studied group, % (n=56) Control group, % (n=21) Studied group, % (n=44) Control group, % (n=19)
214CC 83,9 (47) 76, 2 (16) 79,5 (35) 36,8 (7)
214CА 14,3 (8) 23,8 (5) 15,9 (7) 63,2 (12)
214АА 1,8 (1) –(0) 4,5 (2) –(0)
χ2= 1,31, р=0,52 χ2= 6,54, р=0,01*
Fig. 3. Distribution of р. Leu72Met polymorphous locus genotypes GHRL gene in children with 
GERD with erosive and surface inflammatory changes
There were not revealed any reliable differences as to the frequencies of certain genotypes 
of c.214C>A (р. Leu72Met) locus of GHRL gene in the studied groups of patients, distributed de-
pending on gastrointestinal tract lesion severity. 
5. Discussion
GERD occur in 8,7−17 % of children with gastroenterological diseases [18]. The world expe-
rience of treatment testifies that GERD early diagnostics decreases a risk of complications develop-
ment. [2, 19] Extra-esophageal GERD manifestations [20−22], and revelation of typical esophageal 
symptoms only at 14−15 years old [23] conditions the necessity of searching new diagnostic possi-
bilities. The presence of a genetic component in GERD development is proved by twin studies and 
provides multifactor etiology. [24] Thus, the hypothesis about predisposition genes of GERD devel-
opment is reliable. Identification of such genes and alleles is topical for both early diagnostics and 
prophylaxis of GERD and for the further explanation of their development mechanisms through 
the comprehensive study of pathophysiological processes of these genes expression products. The 
connection between ghrelin and allele polymorphisms of its genes with digestive system diseases 
is specially discussed [2, 5]. 
In the work are presented the results of the distribution of alleles and genotypes of c.214C>A 
(р. Leu72Met) locus of GHRL gene in the group of schoolchildren with GERD comparing with the 
control group of children without a gastrointestinal tract pathology. As it is testified by the results 
of received data statistical processing and determined coefficient of odds ratio that represents a risk 
of GERD development, the differences in genotypes frequencies of the studied and control groups 
are significant like OR coefficients for GHRL 214СС and GHRL 214CА genotype (Table 3). It was 
established, that GHRL 214CС genotype conditions the increase of GERD risk in 3,4 times at the 
credible interval СІ: 1,50–7,56. On the contrary, GHRL 214CА genotype demonstrates the credible 
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protective effect: OR=0,24, СІ: 0,10–0,55. So, in a child with such genotype GERD development 
risk is essentially decreased – 0,24 comparing with a conventional unit. The high reliability degree 
of genotypes distribution differences was received at a premise of recessive type of 214C allele 
of GHRL manifestation (р=0,003). The received data testify that 214C allele in homozygous state 
(Leu/Leu genotype) conditions the increase of GERD development risk in 3,4 times. There was 
shown the expressed protective effect as to GHRL 214А (72Met) allele of GHRL gene: the odds 
ratio coefficient is 0,43 at CI: 0,22–0,88 (Table 2). 
It must be noted that ghrelin gene GERD risk allele is more spread in general population. 
The frequency of minor allele of GHRL 214А (Met72) in the control group was 21 %, and 11 % in 
the studied one. These results concern to Ukrainian population. It must be noted, that the study 
of such genetic locus among Ukrainians was not carried out, and we first inform about the fre-
quencies of alleles of р.Leu72Met locus of GHRL gene. In different ethnic samples its frequency 
is 7,4−22,35 %. It was revealed, that the frequencies of Met72 allele in Europeans are 7,4−12,9 % 
(Vivenza and others, 2004; Bing and others, 2005; Magera and others, 2006; Zavarella and others, 
2008) [25−28]; 18,1 % in Koreans ( Kim and others, 2006) [29] and ~20 % in Japanese (Ando and 
co-author, 2006; Kuzuya and others, 2006) [30,31]. The frequency of Met72 allele in our sample is 
21 %, a bit higher than the data, given by НарМар (15,6 %, N = 90). 
As it is testified by the data, presented in the Table 3, in this work were revealed certain features 
in p.Leu72Met locus genotypes distribution of GHRL in persons of the different sexes. Namely: absence 
of differences in girls group at essential differences among boys. Such results testify that the data about 
GERD risk at Leu/Leu genotype, received in the general studied group, are proved for boys with more 
reliability degree. Thus, the relative risk of GERD for boys at GHRL 214СС (Leu/Leu) genotype is in-
creased in more than 6 times (OR=6,7, СІ: 2,04–21,82). GHRL 214СА (Leu/Met) heterozygous genotype 
is protective as to GERD (OR=0,11, СІ: 0,03–0,38) in boys and in general group. 
6. Conclusions
1. The distribution of alleles and genotypes of c.214C>A (р. Leu72Met) locus of GHRL gene 
in children with GERD was established. 
2. The genetic factor that increases GERD risk is 214 С allele of GHRL gene (Leu) in gen-
otype. GHRL 214CС genotype is associated with a threefold increase of GERD development risk. 
3. Gender differences as to GERD development risk at different genotypes of ghrelin gene 
were established. At GHRL 214СС (Leu/Leu) genotype the relative GERD risk for boys is in-
creased in more than 6 times. GHRL 214СА (Leu/Met) heterozygous genotype is protective as to 
GERD boys and in general group. 
4. Any differences in alleles and genotypes distribution depending on erosive or surface 
inflammatory changes of a gasrtointestinal tract mucosa were not established. 
References
[1] Moayyedi, P., Talley, N. J. (2006). Gastro-oesophageal reflux disease. The Lancet, 367 (9528), 
2086–2100. doi: 10.1016/s0140-6736(06)68932-0
[2] Seyed, M. M., Fatemeh, N., Mahdieh, F., Gholamreza, H., Hamideh, A., Hamid, S. (2015). Ef-
fects of exogenous ghrelin on experimental reflux esophagitis model in male rat. Journal of Physiology and 
Pathophysiology, 6 (2), 6–12. doi: 10.5897/jpap2015.0098
[3] Suzuki, H., Iijima, K., Scobie, G., Fyfe, V., McColl, K. E. L. (2005). Nitrate and nitrosative chem-
istry within Barrett` s oesophagus during acid reflux. Gut, 54 (11), 1527–1535. doi: 10.1136/gut.2005.066043
[4] Asakawa, A., Inui, A., Kaga, O., Yuzuriha, H., Nagata, T., Ueno, N. et. al. (2001). Ghrelin is an 
appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology, 120 (2), 
337–345. doi: 10.1053/gast.2001.22158
[5] Nahata, M., Saegusa, Y., Harada, Y., Tsuchiya, N., Hattori, T., Takeda, H. (2013). Changes in 
Ghrelin-Related Factors in Gastroesophageal Reflux Disease in Rats. Gastroenterology Research and Prac-
tice, 2013, 1–8. doi: 10.1155/2013/504816
Original Research Article:
full paper
(2017), «EUREKA: Health Sciences»
Number 3
16
Medicine and Dentistry
[6] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K. (1999). Ghrelin is a 
growth-hormone-releasing acylated peptide from stomach. Nature, 402 (6762), 656–660. doi: 10.1038/45230
[7] Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T. et. al. (2001). Stomach 
Is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreac-
tivity Levels in Humans. Journal of Clinical Endocrinology & Metabolism, 86 (10), 4753–4758. doi: 10.1210/
jc.86.10.4753
[8] Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M. S., Suganuma, T. et. al. (2000). 
Ghrelin, a Novel Growth Hormone-Releasing Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell 
Type in the Gastrointestinal Tracts of Rats and Humans. Endocrinology, 141 (11), 4255–4261. doi: 10.1210/
en.141.11.4255
[9] Hosoda, H., Kojima, M., Kangawa, K. (2006). Biological, Physiological, and Pharmacological 
Aspects of Ghrelin. Journal of Pharmacological Sciences, 100 (5), 398–410. doi: 10.1254/jphs.crj06002x
[10] Vitolo, E., Santini, E., Seghieri, M., Giannini, L., Coppede, F., Rossi, C. et. al. (2016). Hetero-
zygosity for the rs696217 SNP in the Preproghrelin Gene Predicts Weight Loss After Bariatric Surgery in 
Severely Obese Individuals. Obesity Surgery, 27 (4), 961–967. doi: 10.1007/s11695-016-2387-6
[11] Gueorguiev, M., Lecoeur, C., Meyre, D., Benzinou, M., Mein, C. A., Hinney, A. et. al. (2009). 
Association Studies onGhrelinandGhrelin ReceptorGene Polymorphisms With Obesity. Obesity, 17 (4), 
745–754. doi: 10.1038/oby.2008.589
[12] Monteleone, P., Tortorella, A., Castaldo, E., Di Filippo, C., Maj, M. (2007). The Leu72Met poly-
morphism of the ghrelin gene is significantly associated with binge eating disorder. Psychiatric Genetics, 
17 (1), 13–16. doi: 10.1097/ypg.0b013e328010e2c3
[13] Ukkola, O. (2011). Genetic variants of ghrelin in metabolic disorders. Peptides, 32 (11), 
2319–2322. doi: 10.1016/j.peptides.2011.04.013
[14] Date, Y., Nakazato, M., Murakami, N., Kojima, M., Kangawa, K., Matsukura, S. (2001). Ghrelin 
Acts in the Central Nervous System to Stimulate Gastric Acid Secretion. Biochemical and Biophysical Re-
search Communications, 280 (3), 904–907. doi: 10.1006/bbrc.2000.4212
[15] Nahata, M., Muto, S., Oridate, N., Ohnishi, S., Nakagawa, K., Sadakane, C. et. al. (2012). Im-
paired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux 
disease. AJP: Gastrointestinal and Liver Physiology, 303 (1), G42–G53. doi: 10.1152/ajpgi.00462.2011
[16] Yanai, M., Mochiki, E., Ogawa, A., Morita, H., Toyomasu, Y., Ogata, K. et. al. (2012). Intra-
gastric administration of rikkunshito stimulates upper gastrointestinal motility and gastric emptying in con-
scious dogs. Journal of Gastroenterology, 48 (5), 611–619. doi: 10.1007/s00535-012-0687-8
[17] Krzyzanowska-Swiniarska, B., Kempa, A., Robaczyk, M. (2005). Preproghrelin gene, ghrelin 
receptor and metabolic syndrome. Przegl Lek, 62 (4), 230–233.
[18] Unifikovani klinichni protokoly nadannya dopomogy dityam iz zaxvoryuvannyamy organiv trav-
lennya (2013). MOZ Ukrayiny, No. 59. Available at: http://www.moz.gov.ua/ua/portal/dn_20130129_0059.html
[19] Pediatric Gastroesophageal Reflux Clinical Practice Guidelines (2009). Journal of Pediatric 
Gastroenterology and Nutrition, 49, 498– 547. 
[20] Maev, I. V., Yurenev, G. L., Burkov, S. G. et. al. (2007). Vnepishchevodnye proyavleniya gastro-
ehzofageal’noj reflyuksnoy bolezni. Terapevticheskyi arhiv, 3, 57–66.
[21] Shherbynina, M. B., Budzak, I. Ya. (Eds.) (2008). Kardialni proyavy gastroezofagelnoyi refly-
uksnoyi khvoroby: taktyka vedennya paciyentiv. Kyiv, 23. 
[22] Maev, I. V., Barer, G. M., Busarova, G. A., Pustovoit, E. V., Polikanova, E. N., Burkov, S. G., 
Yurenev, G. L. (2005). Stomatologicheskie proyavleniya gastroehzofageal’noj reflyuksnoj bolezni. Klinich-
eskaya medicina, 11, 33–38. 
[23] Kryuchko, T. O., Nesina, I. M. (2013). Osoblyvosti pozastravokhidnykh proyaviv hastroezofa-
heal’noyi reflyuksnoyi khvoroby u ditey. Zdorov`ya dytyny, 4 (47), 16–19.
Original Research Article:
full paper
(2017), «EUREKA: Health Sciences»
Number 3
17
Medicine and Dentistry
[24] Post, J. C., Ze, F., Ehrlich, G. D. (2005). Genetics of pediatric gastroesophageal reflux. Current 
Opinion in Allergy and Clinical Immunology, 5 (1), 5–9. doi: 10.1097/00130832-200502000-00003 
[25] Vivenza, D., Rapa, A., Castellino, N., Bellone, S., Petri, A., Vacca, G. et. al. (2004). Ghrelin 
gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. 
European Journal of Endocrinology, 151 (1), 127–133. doi: 10.1530/eje.0.1510127
[26] Bing, C., Ambye, L., Fenger, M., Jorgensen, T., Borch-Johnsen, K., Madsbad, S., Urhammer, S. A. 
(2005). Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabol-
ic syndrome and associated quantitative traits. Diabetic Medicine, 22 (9), 1157–1160. doi: 10.1111/j.1464-
5491.2005.01575.x
[27] Mager, U., Kolehmainen, M., Lindstrom, J., Eriksson, J., Valle, T., Hamalainen, H. et. al. (2006). 
Association Between Ghrelin Gene Variations and Blood Pressure in Subjects With Impaired Glucose Toler-
ance. American Journal of Hypertension, 19 (9), 920–926. doi: 10.1016/j.amjhyper.2006.02.017
[28] Zavarella, S., Petrone, A., Zampetti, S., Gueorguiev, M., Spoletini, M., Mein, C. A. et. al. (2007). 
A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin 
gene are associated with protection to insulin resistance. International Journal of Obesity, 32 (4), 663–668. 
doi: 10.1038/sj.ijo.0803766
[29] Kim, S.-Y., Jo, D.-S., Hwang, P. H., Park, J. H., Park, S. K., Yi, H. K., Lee, D.-Y. (2006). Pre-
proghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism, 55 (3), 
366–370. doi: 10.1016/j.metabol.2005.09.011
[30] Ando, T., Komaki, G., Naruo, T., Okabe, K., Takii, M., Kawai, K. et. al. (2006). Possible role of 
preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. American Journal of Medical Genet-
ics Part B: Neuropsychiatric Genetics, 141B (8), 929–934. doi: 10.1002/ajmg.b.30387
[31] Kuzuya, M., Ando, F., Iguchi, A., Shimokata, H. (2006). Preproghrelin Leu72Met variant 
contributes to overweight in middle-aged men of a Japanese large cohort. International Journal of Obesity, 
30 (11), 1609–1614. doi: 10.1038/sj.ijo.0803296
